These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 6827098)

  • 21. Comparison of antigenic sources for acetylcholine receptor antibody assays in myasthenia gravis.
    McAdams MW; Roses AD
    Ann Neurol; 1980 Jul; 8(1):61-6. PubMed ID: 6773466
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Kinetic studies on neurotoxin-binding inhibitory antibodies in myasthenia gravis.
    Ito A; Furukawa S; Satoyoshi E; Sakurai H
    Clin Chim Acta; 1985 Nov; 152(3):315-23. PubMed ID: 2998645
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Heterogeneity of acetylcholine receptor antibodies in patients with myasthenia gravis].
    Kalies I; Heinz F; Kaschka WP; Druschky KF; Kalden JR
    Klin Wochenschr; 1984 Apr; 62(8):377-85. PubMed ID: 6727277
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Absence of anti-acetylcholine receptor antibodies in Praomys (Mastomys) natalensis.
    Vincent A; Solleveld HA
    Clin Exp Immunol; 1981 Jan; 43(1):94-8. PubMed ID: 7249398
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An assessment of radioimmunoassay procedures for determination of anti-acetylcholine receptor antibodies in the sera of patients with myasthenia gravis.
    Carter B; Harrison R; Lunt GG; Morris H; Savage-Marengo T; Stephenson FA
    Ann Clin Biochem; 1981 May; 18(Pt 3):146-52. PubMed ID: 7283364
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Assay of acetylcholine receptor antibodies in myasthenia gravis. A study of 329 sera (author's transl)].
    Morel E; Raimond F; Goulon-Goëau C; Berrih S; Vernet-Der-Garabedian B; Harb J; Bach JF
    Nouv Presse Med; 1982 May; 11(24):1849-54. PubMed ID: 7110933
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunological specificity and cross-reactivity of anti-acetylcholine receptor and anti-presynaptic membrane receptor antibodies in myasthenia gravis.
    Xiao BG; Lu CZ; Höjeberg B; Link H
    J Neurol Sci; 1991 Sep; 105(1):118-23. PubMed ID: 1665503
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Myasthenic antibodies cross-link acetylcholine receptors to accelerate degradation.
    Drachman DB; Angus CW; Adams RN; Michelson JD; Hoffman GJ
    N Engl J Med; 1978 May; 298(20):1116-22. PubMed ID: 643030
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antibody to acetylcholine receptor in myasthenia gravis. Prevalence, clinical correlates, and diagnostic value.
    Lindstrom JM; Seybold ME; Lennon VA; Whittingham S; Duane DD
    Neurology; 1976 Nov; 26(11):1054-9. PubMed ID: 988512
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Purification of anti-acetylcholine receptor antibody from patients with myasthenia gravis.
    Lang B; Vincent A; Newsom-Davis J
    J Immunol Methods; 1982; 51(3):371-81. PubMed ID: 7108235
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Detection of anti-acetylcholine receptor antibody by an ELISA using human receptor from a rhabdomyosarcoma cell line.
    Martino G; Twaddle G; Brambilla E; Grimaldi LM
    Acta Neurol Scand; 1994 Jan; 89(1):18-22. PubMed ID: 8178622
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Acetylcholine receptor antibody as a diagnostic test for myasthenia gravis: results in 153 validated cases and 2967 diagnostic assays.
    Vincent A; Newsom-Davis J
    J Neurol Neurosurg Psychiatry; 1985 Dec; 48(12):1246-52. PubMed ID: 4087000
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Myasthenia gravis without acetylcholine-receptor antibody: a distinct disease entity.
    Mossman S; Vincent A; Newsom-Davis J
    Lancet; 1986 Jan; 1(8473):116-9. PubMed ID: 2417076
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Myasthenia gravis. Anti-acetylcholine receptor antibodies.
    Cerrato D; Ariano C; La Mantia L; Fiacchino F; Sghirlanzoni A; Nespolo A; Corridori F; Cornelio F
    Ital J Neurol Sci; 1981 May; 2(2):165-71. PubMed ID: 7333817
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Future therapeutic strategies in autoimmune myasthenia gravis.
    Psaridi-Linardaki L; Mamalaki A; Tzartos SJ
    Ann N Y Acad Sci; 2003 Sep; 998():539-48. PubMed ID: 14592926
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Improved radioassay of anti-acetylcholine receptor antibody: application for the detection of extremely low antibody titers in sera from patients with myasthenia gravis.
    Ohta M; Ohta K; Mori F; Itoh N; Nishitani H; Hayashi K
    Clin Chem; 1990 Jun; 36(6):911-3. PubMed ID: 2357833
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A sensitive non-isotopic assay for acetylcholine receptor autoantibodies.
    Hewer R; Matthews I; Chen S; McGrath V; Evans M; Roberts E; Nute S; Sanders J; Furmaniak J; Smith BR
    Clin Chim Acta; 2006 Feb; 364(1-2):159-66. PubMed ID: 16051208
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Patient-specific anti=acetylcholine receptor antibody patterns in myasthenia gravis.
    Savage-Marengo T; Harrison R; Lunt GG; Behan PO
    J Neurol Neurosurg Psychiatry; 1980 Apr; 43(4):316-20. PubMed ID: 7373331
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A simplified ELISA for anti-receptor antibodies in myasthenia gravis.
    Jailkhani BL; Asthana D; Jaffery NF; Kumar R; Ahuja GK
    J Immunol Methods; 1986 Jan; 86(1):115-8. PubMed ID: 3944465
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antibodies from myasthenic patients that compete with cholinergic agents for binding to nicotinic receptors.
    Fulpius BW; Miskin R; Reich E
    Proc Natl Acad Sci U S A; 1980 Jul; 77(7):4326-30. PubMed ID: 6933485
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.